AstraZeneca – AstraZeneca PLC ADR outperforms market on strong trading day
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A136F73DEE77C62D93C3D7C15E6EF63B8%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%274d40d364-d489-4bff-8c58-d057e5d10dc4%27&-ver=%271.0%27&-impressionGuid=%274d40d364-d489-4bff-8c58-d057e5d10dc4%27&-pageName=%27articleflex%27&-uri=%27https%253A%252F%252Fwww.msn.com%252Fen-us%252Fmoney%252Ftopstocks%252Fastrazeneca-plc-adr-outperforms-market-on-strong-trading-day%252Far-BB1d5eRy%253Focid%253Dfinance-verthp-feeds%27&-referrerUri=%27http%3A%2F%2Fwww.bing.com%2F%27&-pageTags=%27{"pg.t"%3A"article"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"4d40d364d4894bff8c58d057e5d10dc4"%2C"clid"%3A"136F73DEE77C62D93C3D7C15E6EF63B8"%2C"clidType"%3A"muid"%2C"di"%3A"7290"%2C"partner"%3A"MarketWatch"%2C"publcat"%3A"Dow%2BJones%2B%2526%2BCompany%252c%2BInc."%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"BB1d5eRy"%2C"entitySrc"%3A"ar"%2C"provid"%3A"AA28LZ"%2C"dpt"%3A"finance-top-stocks"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"tmx.pc.webkit.chrome.chrome76plus"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-us%27){kind=small}
© Terrence Horan
![a close up of a stage](https://www.msn.com/en-us/money/topstocks/astrazeneca-plc-adr-outperforms-market-on-strong-trading-day/{"default":{"load":"default","w":"80","h":"56","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1aZQlZ.img?h=556&w=799&m=6&q=60&o=f&l=f"},"size3column":{"load":"default","w":"62","h":"43","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1aZQlZ.img?h=434&w=624&m=6&q=60&o=f&l=f"},"size2column":{"load":"default","w":"62","h":"43","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1aZQlZ.img?h=434&w=624&m=6&q=60&o=f&l=f"}})
COMPANY CLOSE UPDATES
The AstraZeneca PLC ADR (AZN) rallied 1.43% to $54.01 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.69% to 13,635.99 and the Dow Jones Industrial Average DJIA falling 0.12% to 30,960.00. This was the ADR’s third consecutive day of gains. AstraZeneca PLC ADR closed $10.93 below its 52-week high ($64.94), which the company achieved on July 20th.
Video: More dividend growth expected in Covid cyclicals, says analyst (CNBC)
UP NEXT
The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. ABBV fell 0.32% to $110.50, Amgen Inc. AMGN rose 1.42% to $257.10, and Gilead Sciences Inc. GILD rose 1.82% to $68.16. Trading volume (13.7 M) eclipsed its 50-day average volume of 11.6 M.
Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.
Microsoft may earn an Affiliate Commission if you purchase something through recommended links in this article.
Send MSN Feedback
Please give an overall site rating:
Opens in a new window
Opens an external site
Opens an external site in a new window
